Dr. Agarwal's Health Care Ltd

Ticker: AGARWALEYE
Decent 68/100

☆ Add to Watchlist
Breakout

Investing Reference

Price
522.40
Market Cap
16516.11
Debt/Equity
0.4987
ROE %
5.048
PB
8.5717
Promoter %
32.422
Pledge %
0.000
1Y Rev Growth %
27.649
5Y Rev Growth %
26.438
NP Margin %
4.750
NP Margin 5Y Avg %
2.713

Trading Reference

1M Return %
19.972
6M Return %
27.290
1Y Return %
30.063
% Away 52W High
3.982
% Away 52W Low
59.755
Daily Volume
242147
Investment Verdict
Risky
Score 47/100 · Position size: 6%
Higher volatility/weak areas. Consider only a small allocation if risk appetite is high.
Trading Verdict
Momentum
Score 79/100 · Position size: 20%
Momentum weak or trend adverse. Avoid trading at this point.
Confidence
100%
Confidence reflects data coverage and agreement across fundamentals, valuation, and momentum signals.

AI Probability Statement

Probability Statement

Dr. Agarwal's Health Care Ltd is currently trading near a key support level, with the 50-day EMA indicating a bullish trend. If the stock breaks above the recent resistance level, there is a strong potential for upward momentum. However, if it falls below the support, downside risks could materialize.
Upside Probability: 20%   |   Downside Probability: 15%

Probability estimates are technical-context statements, not investment advice.

More Options

Business Overview

Dr. Agarwal's Health Care Ltd is a leading healthcare provider in India, dedicated to delivering high-quality eye care services. With a network of advanced eye hospitals and a commitment to patient-centric care, it caters to individuals seeking reliable and effective eye treatments. The organization is renowned for its innovative approaches and experienced professionals, ensuring optimal outcomes for patients. As a trusted name in healthcare, it plays a crucial role in enhancing the quality of life for countless individuals across the nation.

  • Established leader in eye care services
  • Wide network of advanced eye hospitals
  • Patient-centric approach to healthcare
  • Innovative treatments and technologies
  • Experienced and skilled medical professionals
  • Commitment to improving community health

Investment Thesis

Dr. Agarwal's Health Care Ltd stands out due to its credible promoter group, robust growth in digital health services, and attractive valuation compared to peers. These factors position the company for sustained growth and value creation in the healthcare sector.

  • Strong promoter group with a proven track record enhances credibility and investor confidence.
  • Significant growth potential in digital health services aligns with industry trends and consumer demand.
  • Valuation metrics indicate the stock is attractively priced relative to its peers, offering a compelling entry point.
  • Expansion plans and strategic partnerships are set to drive revenue growth and market share.
  • Focus on innovation and technology integration positions the company for long-term success.

Opportunity vs Risk

Opportunities
  • Growing healthcare demand in India
  • Expansion into tier-2 cities
  • Strong brand recognition
  • Potential for telemedicine services
  • Rising health awareness among consumers
Risks ⚠️
  • Regulatory changes affecting operations
  • Intense competition in healthcare sector
  • Economic downturn impacts spending
  • High operational costs
  • Dependence on skilled workforce

Peer Perspective

Dr. Agarwal's Health Care Ltd trades at a discount compared to peers like Apollo Hospitals and Fortis Healthcare, necessitating sustained margin stability and growth acceleration for potential rerating in the competitive healthcare sector.

Future Outlook

Dr. Agarwal's Health Care Ltd is well-positioned for growth, driven by expanding services and market demand; however, successful execution and cost control will be crucial to fully realize its potential.

AI FAQs for Retail Users

  • Q: What does Dr. Agarwal's Health Care Ltd do?
    A: Dr. Agarwal's Health Care Ltd provides eye care services through a network of hospitals and clinics.
  • Q: Is Dr. Agarwal's Health Care Ltd a profitable company?
    A: The company has reported profits in recent years, but past performance does not guarantee future results.
  • Q: What are the growth prospects for Dr. Agarwal's Health Care Ltd?
    A: The company aims to expand its services and reach more patients in India and abroad.
  • Q: How can I invest in Dr. Agarwal's Health Care Ltd?
    A: You can invest through a stockbroker or an online trading platform that offers access to Indian stocks.
  • Q: What are the risks of investing in Dr. Agarwal's Health Care Ltd?
    A: Like all stocks, it carries risks including market volatility and changes in the healthcare sector.
📊 Stock Investment Checklist (100 Points)
Dr. Agarwal's Health Care Ltd • Updated: 2025-09-16 20:32:36
  • 10
    Business
    High
    The healthcare sector is growing, but competition is intense.
  • 10
    Growth
    High
    Revenue growth has been consistent, but profit margins are under pressure.
  • 10
    Profitability
    High
    ROE and ROCE are decent, but OCF is fluctuating.
  • 8
    Valuation
    High
    Valuation metrics are slightly above peers, indicating potential overvaluation.
  • 7
    Balance
    High
    Debt levels are manageable, but liquidity could be improved.
  • 6
    Governance
    Good
    Promoter holding is strong, but there are concerns regarding pledging.
  • 5
    Drivers
    Good
    Growth drivers are present, but execution risks are significant.
  • 5
    Technicals
    Good
    Market sentiment is neutral with low liquidity.
Final Score & Verdict
Score 68 / 100 • Decent
Dr. Agarwal's Health Care Ltd shows potential for growth but faces challenges in profitability and valuation. Investors should proceed with caution.

AI Confidence Score

Instead of just “overall score,” broken into categories:

  • Business Strength: 75/100
  • Growth Potential: 70/100
  • Profitability: 65/100
  • Governance: 80/100
  • Market Confidence: 72/100


More Like This

Latest News

More ↗

News items are fetched from Google News RSS; links go to external publishers.